Core Viewpoint - Nvidia reported impressive Q4 results with sales of $68.12 billion and EPS of $1.62, reflecting year-over-year growth of 73% and 82% respectively, yet the stock has declined over 6% post-report due to investor concerns about the sustainability of the AI boom and concentration risks [1][2]. Financial Performance - Q4 sales reached $68.12 billion, with an EPS of $1.62, marking significant year-over-year increases of 73% and 82% [1]. - For fiscal 2027, Nvidia provided a revenue guidance of $78 billion, exceeding analysts' expectations of $72.8 billion, indicating at least 73% year-over-year growth and 12% sequential growth [6]. - EPS estimates for FY27 and FY28 have increased over 3% in the past week, with a projected annual earnings leap of 60% in FY27 and a further 20% increase in FY28 to $9.13 per share [8]. Market Concerns - Analysts express skepticism regarding the sustainability of AI spending by hyperscalers, questioning whether the pace of AI monetization justifies the current expenditures [3]. - Nvidia's revenue is heavily reliant on data centers, with 90% coming from five major cloud providers, raising concerns about potential order slowdowns from these customers [4]. - Increased competition from AMD and the development of in-house AI accelerators by major hyperscalers like Alphabet and Amazon pose risks to Nvidia's market position and profit margins [5]. Valuation Metrics - Nvidia is currently trading near its lowest forward P/E valuation in a decade, offering a discount compared to its historical median of 45X and below its peak of 118X [10]. - The stock is trading at a slight premium to the S&P 500 and below the Zacks Semiconductor-General Industry average of 27X [10]. Conclusion - Despite concerns regarding AI sustainability, Nvidia continues to show strong demand and structural dominance in the market, suggesting that it remains a compelling investment opportunity [13]. - The positive trend in EPS revisions supports a strong buy rating for Nvidia stock [14].

Chart Industries (GTLS) came out with quarterly earnings of $2.51 per share, missing the Zacks Consensus Estimate of $3.48 per share. This compares to earnings of $2.66 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -27.82%. A quarter ago, it was expected that this equipment maker for the energy sector would post earnings of $3.01 per share when it actually produced earnings of $2.78, delivering a surprise of -7.64%.Over the ...

Agnico Eagle Mines (AEM) ended the recent trading session at $251.60, demonstrating a +2.11% change from the preceding day's closing price. This change outpaced the S&P 500's 0.43% loss on the day. Meanwhile, the Dow experienced a drop of 1.05%, and the technology-dominated Nasdaq saw a decrease of 0.92%. The gold mining company's shares have seen an increase of 14.33% over the last month, surpassing the Basic Materials sector's gain of 7.73% and the S&P 500's loss of 0.5%.The investment community will be c ...

Year to date sales growth of Dream Water® E-commerce of 26% offset by a decline of Dream Water® Retail of 4% compared to same period last yearYear to date sales growth of LivRelief™ E-commerce of 28 % offset by a decline in LivRelief™ Retail of 29% compared to same period last yearVancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health an ...

Investors obviously didn't figure a significant bottom-line miss was in the cards for Figure Technology Solutions' (NASDAQ: FIGR) final quarter of 2025. That's a key reason they traded out of the next-generation fintech company's stock on Friday. As a result, it declined by a steep 25%-plus that day. Business on the blockchain Figure, which harnesses blockchain technology to automate mortgage and home equity loan services, unveiled its fourth-quarter and full-year results after market close Thursday. Th ...

Teva Pharmaceutical Industries (NYSE: TEVA) is an interesting investment story. For the right investor, it could be an attractive buy. For me, however, it isn't. Here's the opportunity that Teva has ahead of it, and why that opportunity just doesn't interest me. What does Teva Pharmaceutical do? Historically, Teva produced generic drugs, which can be a lucrative business model. Essentially, some other pharmaceutical company puts in the time, effort, and expense of developing a medication. That company is ...

Core Viewpoint - The U.S. Department of Defense has designated Anthropic as a supply chain risk to national security after the company declined to provide unrestricted access to its AI models, leading to a potential loss of a $200 million government contract [1][7]. Group 1: Government Actions and Statements - Defense Secretary Pete Hegseth emphasized the need for the Department of Defense to have full access to Anthropic's AI models, stating that no contractor working with the military should engage in commercial activities with the company [2]. - President Trump accused Anthropic of attempting to manipulate the government and stated that the U.S. military would not allow a "radical left, woke company" to dictate military operations [2][6]. - The Pentagon has denied intentions to use Anthropic's technology for mass surveillance or autonomous weapons, claiming that the company is misrepresenting the situation [6]. Group 2: Anthropic's Position - Anthropic rejected the Pentagon's request for unrestricted access to its AI models, citing ethical concerns regarding the use of its technology for mass surveillance and fully autonomous weapons [3]. - The company indicated it would facilitate a transition to another provider if the Department of Defense decided to terminate its contract [3]. Group 3: Impact on Other Companies - Palantir, which has significant government contracts, will need to sever ties with Anthropic to maintain its relationship with the Defense Department, as it utilizes Anthropic's AI models [5]. - Lockheed Martin has been asked by the Department of Defense to evaluate its reliance on Anthropic, while Amazon Web Services may also be affected due to its involvement in training Anthropic's AI models [5]. Group 4: Industry Support and Reactions - A petition supporting Anthropic has been signed by 266 Google and 65 OpenAI employees, advocating for the company's stance against the use of its models for mass surveillance and autonomous weaponry [8].

Deribit’s flagship podcast, ‘Crypto Options Unplugged,’ marks its 100th episode this week, representing a significant milestone for institutional crypto derivatives media. The weekly show, which has become a staple for professional traders and investors, celebrated the occasion with a special broadcast from Deribit’s London studio. Related: Inflation data sends markets reeling From first steps to a century of episodes The podcast began its journey on Jan. 19, 2024. Over the past two years, the show has ...

Company Overview - Oddity Tech Ltd. operates as a consumer technology company focused on building digital-first brands within the beauty and wellness industries [3] Financial Results and Issues - On February 25, 2026, Oddity reported its full year 2025 financial results, revealing a significant dislocation in its account with its largest advertising partner due to algorithm changes. This led to a diversion to lower quality auctions at abnormally high costs, resulting in increased new user acquisition costs that are not aligned with market trends or historical performance [4] - Following the announcement of these financial results, Oddity's stock price experienced a dramatic decline of over 49% [4] Legal Investigation - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Oddity Tech Ltd. [1]

Core Viewpoint - Paramount Skydance has received strong support from its controlling shareholders, including the Ellison family, for an equity offering aimed at funding a significant deal [1] Group 1 - The equity offering is fully backed by the controlling shareholders, indicating their confidence in the company's strategic direction [1] - The involvement of the Ellison family highlights the importance of key stakeholders in the company's financial decisions [1]